Risk‐Reducing Gender‐Affirming Mastectomy: Unique Considerations in BRCA
Date
2025-03-27
Language
American English
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Wiley
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract
Individualized breast cancer risk assessment should be considered for transmasculine patients pursuing gender-affirming mastectomy to identify and educate high-risk patients about the option for risk-reduction gender-affirming mastectomy. This reduces oncologic risk while achieving the desired cosmetic outcome, ultimately enhancing preventative care provided to an underserved population.
Description
Keywords
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Johnson BN, Hadad I, Hassanein AH, Fisher CS. Risk-Reducing Gender-Affirming Mastectomy: Unique Considerations in BRCA. Clin Case Rep. 2025;13(4):e70336. Published 2025 Mar 27. doi:10.1002/ccr3.70336
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Clinical Case Reports
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
Version
Final published version